Looker vs Recursion
Side-by-side comparison to help you choose the best tool.
Looker
paidLooker (Google Cloud) is a business intelligence and data analytics platform known for its LookML semantic layer, which centralises metric definitions and enables consistent reporting across the organisation. Its AI features include Looker Studio with generative AI data, AI-assisted LookML generation, and integration with Gemini for natural language data exploration. Acquired by Google, Looker is the leading BI platform for organisations on Google Cloud.
Recursion
paidRecursion is a clinical-stage biotechnology company using AI to industrialise drug discovery. It combines large biological image datasets with ML to identify disease-biology relationships and predict therapeutic candidates. Recursion's platform has generated one of the largest proprietary biological datasets in existence, enabling AI-driven target identification and compound screening at new scale.
| Feature | Looker | Recursion |
|---|---|---|
| Pricing | paid | paid |
| Category | Data & Analytics | Data & Analytics |
| Rating | 4.4 | 4.4 |
| Best For | Data and analytics teams on Google Cloud wanting a governed semantic layer with AI natural language querying and embedded analytics | Pharmaceutical partners seeking AI drug discovery collaboration with one of the world's leading clinical-stage AI biotech companies |
| Views | 67 | 66 |
Pros
- LookML semantic layer ensures metric consistency org-wide
- Best BI platform for Google Cloud environments
- Embedded analytics capabilities are best-in-class
Cons
- LookML has a steep learning curve
- Less flexible than Tableau for ad-hoc exploration
Pros
- Pioneer in AI-driven drug discovery at scale
- Proprietary dataset is a competitive moat
- Active clinical programmes validate the approach
Cons
- Pharmaceutical industry-specific
- Platform not publicly available
- LookML semantic layer for consistent metrics
- Gemini AI natural language querying
- Embedded analytics
- AI-assisted LookML generation
- Real-time data exploration
- AI-powered target identification
- Large-scale biological image analysis
- ML compound screening
- Disease-biology mapping
- Partnership programs